| Title : Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease - Parsons_2013_Neurotox.Res_24_358 |
| Author(s) : Parsons CG , Danysz W , Dekundy A , Pulte I |
| Ref : Neurotox Res , 24 :358 , 2013 |
| Abstract : Parsons_2013_Neurotox.Res_24_358 |
| ESTHER : Parsons_2013_Neurotox.Res_24_358 |
| PubMedSearch : Parsons_2013_Neurotox.Res_24_358 |
| PubMedID: 23657927 |
| Title : Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease - Francis_2012_Expert.Rev.Neurother_12_1351 |
| Author(s) : Francis PT , Parsons CG , Jones RW |
| Ref : Expert Rev Neurother , 12 :1351 , 2012 |
| Abstract : Francis_2012_Expert.Rev.Neurother_12_1351 |
| ESTHER : Francis_2012_Expert.Rev.Neurother_12_1351 |
| PubMedSearch : Francis_2012_Expert.Rev.Neurother_12_1351 |
| PubMedID: 23234396 |
| Title : Inhibition of the alpha9alpha10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-D-aspartate receptors - Plazas_2007_Eur.J.Pharmacol_566_11 |
| Author(s) : Plazas PV , Savino J , Kracun S , Gomez-Casati ME , Katz E , Parsons CG , Millar NS , Elgoyhen AB |
| Ref : European Journal of Pharmacology , 566 :11 , 2007 |
| Abstract : Plazas_2007_Eur.J.Pharmacol_566_11 |
| ESTHER : Plazas_2007_Eur.J.Pharmacol_566_11 |
| PubMedSearch : Plazas_2007_Eur.J.Pharmacol_566_11 |
| PubMedID: 17466293 |